Instead, the percentage of LCN2+ cells among CD45+ cells and the number of LCN2+CD45+ cells were significantly increased in the tumor after stroke, suggesting that the increased LCN2 were mainly derived from leukocytes (Figure 4A). The gene discussed is PTPRC; the disease is stroke disorder.